Promoter holding
64.27%
PI
Pax I-Bio Tech Private Limited - Due diligence report
A 360° intelligence report on Pax I-Bio Tech Private Limited: trust score, financial health, credit view, compliance, directors, growth and …
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Pax I-Bio Tech Private Limited — 360° Intelligence Report
Generated from MCA filings & public records56/100
Trust Score
Moderate
Pax I-Bio Tech Private Limited is assessed as Moderate with a Trust Score of 56/100. Pax I-Bio Tech Private Limited is an active private limited indian non-government company incorporated in 2000, operating in the Information Technology sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.
Report generated on 17 Jul 2026 from the latest processed filings. Pax I-Bio Tech Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
56/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
75/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
5/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreCaution Indicated
30/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
- Negative operating earnings - debt service depends on external support.
- No open charges - unencumbered balance sheet.
Charges position: 0 open (-) · 0 satisfied (-).
Compliance Score: 75/100 Low Risk
- Company status is Active as per MCA.
- Last balance sheet is for Mar 2021 - filings overdue.
05
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| XERXES PERVEZ BATLIWALA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| RAJSHREE ASHOK PATHARE | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SHREYAS ALIAS ASHOK NARAYAN PATHARE | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 3 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
06
Ownership & Group Intelligence
As per FY 2021 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
2 allotment(s) · 0 transfer(s)
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 40 · Distress 30
Growth signals & trust indicators
Operating for 25+ years.
Distress signals & risk flags
Revenue declined year-on-year.
Losses deepening year-on-year.
Negative net worth.
Statutory filings appear overdue.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence56/100
Review suggested
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- 4 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment40/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- No existing security registered - first-charge position available.
- Compliance record supports lending.
Investor view32/100
Limited indicators at present
Growth quality and scalability through an investor lens.
- No clear growth signals in the filed years.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 8 events30 Nov 2021
Last AGM held
Annual general meeting
31 Mar 2021
Latest balance sheet
Filed with ROC
01 Jan 2018
Director appointed
RAJSHREE ASHOK PATHARE (Additional Director)
02 Sep 2010
Securities allotted
9800 Equity Shares Without Differential Rights - 98,000.00 raised
02 Apr 2002
Securities allotted
9800 Equity Shares Without Differential Rights - 98,000.00 raised
20 Oct 2000
Incorporated
Registered with Roc Mumbai I
Director appointed
XERXES PERVEZ BATLIWALA (Director)
Director appointed
SHREYAS ALIAS ASHOK NARAYAN PATHARE (Director)
10
Key Observations
Auto-generated from the data aboveRevenue declined 38% over the last 4 financial year(s).
Net profit margin moved from 1.42 to 2.1x.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
Promoters hold a dominant controlling stake as per the FY 2021 annual return.
Capital has been raised through 2 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| Cloudverge Software Solutions Private Limited | U72900TN2019PTC128212 | Chennai, Tamil Nadu, India |
| Techdia Private Limited | U72900KL2019PTC059939 | Thrikkakara North, Kerala, India |
| Goodwill Lubricants Private Limited | U23201TG2002PTC039367 | Rajendranagar, Telangana, India |
| Virudhunagar Kamaraj Memorial Software Private Limited | U72900TN2009PTC071090 | Madurai, Tamil Nadu, India |
| Chrysalis Software & Systems | U72200PN2011PTC141796 | Ahmednagar, Maharashtra, India |
| Protech Systems Private Limited | U74899DL1989PTC035951 | New Delhi, Delhi, India |
| Karthavya It Solutions | U72200KA2013PTC067926 | Bangalore, Karnataka, India |
| Zaptune Software Private Limited | U72200DL2010PTC200159 | Delhi, Delhi, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Pax I-Bio Tech Private Limited before audits and certifications: compliance score 75/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Pax I-Bio Tech Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Enhanced diligence advised. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Limited indicators at present. Growth score 40/100, margin trends, ownership structure and peer set for Pax I-Bio Tech Private Limited - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Review suggested. Trust score 56/100, distress signals and MSME payment-delay disclosures - know whether Pax I-Bio Tech Private Limited pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Pax I-Bio Tech Private Limited - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Pax I-Bio Tech Private Limited an active company?
Pax I-Bio Tech Private Limited has MCA status “Active” with a compliance score of 75/100 (Low Risk).
Is Pax I-Bio Tech Private Limited financially healthy?
Pax I-Bio Tech Private Limited has a Financial Health Score of 5/100 (Caution Indicated) based on its filed financial statements.
Should I do business with Pax I-Bio Tech Private Limited?
Its overall Trust Score is 56/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Pax I-Bio Tech Private Limited?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.
Does Pax I-Bio Tech Private Limited have loans or charges against its assets?
No charges are registered against this company - an unencumbered balance sheet.
Is Pax I-Bio Tech Private Limited up to date with its ROC filings?
Last balance sheet is for Mar 2021 - filings overdue. Overall compliance score: 75/100 (Low Risk).
Is it risky to lend to Pax I-Bio Tech Private Limited?
Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
